Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.83 USD | -2.03% |
|
+0.99% | +4.07% |
Jul. 09 | RBC Lifts Price Target on Axsome Therapeutics to $131 From $130, Keeps Outperform Rating | MT |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.07% | 4.02B | |
+6.96% | 98.81B | |
+8.29% | 42.32B | |
-11.09% | 34.48B | |
+82.32% | 29.83B | |
-11.82% | 15.93B | |
+1.39% | 14.01B | |
-12.13% | 11.52B | |
+176.65% | 10.45B | |
+6.74% | 9.06B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Sector Update: Health Care Stocks Carried Higher in Rising Tuesday Markets